期刊文献+

染色体微阵列分析实验室技术要求专家共识 被引量:10

Expert consensus on chromosomal microarray analysis laboratory technical requirements
原文传递
导出
摘要 染色体微阵列分析(chromosomal microarray analysis,CMA),是以微阵列为技术基础的基因组拷贝数变异(copy number variations,CNVs)分析技术,主要包括基于比较基因组杂交的微阵列(array-based comparative genomic hybridization,aCGH)和基于单核苷酸多态性的微阵列(single nucleotide polymorphism array,SNP array)。CMA是一种高分辨率的全基因组染色体变异检测技术,近年来其在临床的应用逐步深入和广泛,国内外已出台相关指南与专家共识以推动其在临床的规范应用。为进一步规范染色体微阵列分析技术的临床应用,保证医疗质量与医疗安全,国家卫生健康委员会临床检验中心产前筛查与诊断室间质量评价专家委员会组织专家进行了充分讨论,拟在CMA实验室技术等方面作出规范和建议,以规范CMA技术在遗传病诊断领域中的应用。随着技术的更新与成熟,本共识将持续更新以满足临床需求。
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2019年第9期745-751,共7页 Chinese Journal of Laboratory Medicine
  • 相关文献

二级参考文献43

  • 1Brady PD, Vermeesch JR. Genomic microarrays: a technology overview[J]. Prenat Diagn, 2012,32:336-343.
  • 2Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet, 2010,86: 749-764.
  • 3Hillman SC, McMullan DJ, Hall G, et al. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol, 2013,41:610-620.
  • 4Shaffer LG, Dabell MP, Fisher AJ, et al. Experience with microarray-based comparative genomie hybridization for prental diagnosis in over 5000 pregnancies[J]. Prenat Diagn, 2012,32: 976-985.
  • 5Shaffer LG, Dosenfeld JA, Dabell MP, et al. Detection rates of clinically significant genomie alterations by mieroarray analysis for specific anomalies detected by ultrasound[J]. Prenat Diagn, 2012,32:986-995.
  • 6Wapner R J, Marthin CL, Lery B, et al. Chromosomal microarray versus karyotyping for prental diagnosis[J]. N Engl J Med, 2012, 367:2175-2184.
  • 7American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis[J]. Obstet Gynecol,2013,122:1374-1377.
  • 8Roychowdhury S,Chinnaiyan AM. Translating cancer genomesand transcriptoraes for precision oncology [ J]. CA Cancer J Clin,2016,66(1) :75-88. DOI: 10. 3322/caac. 21329.
  • 9Porto G, Brissot P,Swinkels DW, et al. EMQN best practiceguidelines for the molecular genetic diagnosis of hereditaryhemochromatosis ( HH) [J/OL]. Eur J Hum Genet, 2015 [2015-12-14 ]. http://www. ncbi. nlm. nih. gov/pubmed/? term =26153218. [ published online ahead of print Jul 8,2015 ]. DOI:10.1038/ejhg. 2015.128.
  • 10Mr6zek K, Marcucci G, Nicolet D, et al. Prognostic significanceof the European LeukemiaNet standardized system for reportingcytogenetic and molecular alterations in adults with acute myeloidleukemia[J].J Clin Oncol, 2012, 30(36) :45154523. D01:10.1200/100.2012.43.4738.

共引文献301

同被引文献67

引证文献10

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部